Insulin Regular

ApprovedSmall molecule

TThe University of Texas Medical Branch, Galveston

Insulin Regular is one of 94 small molecule programs targeting Hyperkalemia. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HyperkalemiaActive, not recruiting

Wound HealingActive, not recruiting

HyperglycemiaActive, not recruiting

SarcopeniaActive, not recruiting

HyperkalemiaApproved

Active, not recruiting

Wound HealingPhase 2/Phase 3

Active, not recruiting

HyperglycemiaPreclinical

Active, not recruiting

SarcopeniaPhase 1

Active, not recruiting

Competition

Competitive Landscape

133 competitors in Wound Healing

#DrugCompanyPhaseTrials

Avastin

BBio-Thera Solutions

Phase 3

1 2

Januvia

ZZydus Therapeutics Inc.

Phase 3

1 3

Glucophage

EMD Serono

Phase 3

1 4

Insulin Regular

TThe University of Texas Medical Branch, Galveston

Approved

1 5

Growth Hormone

Pfizer

Phase 3

1 6

Vaseline

MMassachusetts General Hospital

Phase 3

1 7

Becaplermin

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

1 8

Oxandrolone and Propranolol

TThe University of Texas Medical Branch, Galveston

Phase 3

1 9

Nicorette

Pfizer

Preclinical

1 10

Zofran

Novartis

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hyperkalemia1 trial

5 Versus 10 Units of Insulin in Hyperkalemia Management

Completed·OOman Medical Speciality Board·Phase 4·NCT06036823·384 enrolled

Hyperglycemia1 trial

Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia

Completed·—·N/A·NCT06178874·90 enrolled

Sarcopenia1 trial

Insulin and Sarcopenia in the Elderly

Completed·TThe University of Texas Medical Branch, Galveston·Phase 1·NCT00690534·88 enrolled

Wound Healing1 trial

Assessment of Mechanisms of Improved Wound Healing

Completed·TThe University of Texas Medical Branch, Galveston·Phase 2/3·NCT00673309·644 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Insulin Regular. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Insulin Regular compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Insulin Regular. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The University of Texas Medical Branch, Galveston company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: TThe University of Texas Medical Branch, Galveston

Insulin Regular

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hyperkalemia1 trial

Hyperglycemia1 trial

Sarcopenia1 trial

Wound Healing1 trial

References

Drug Info

Quick Facts

Related News